Community Pharmacists' Preparedness for COVID-19 Testing in Nigeria
Keywords:
COVID-19 testing, community pharmacists, knowledge, preparedness, willingnessAbstract
Background: The Nigeria Centre for Disease Control recently approved the use of Antigen based rapid diagnostic test kits for the diagnosis of COVID-19 in Nigeria, with the goal to scale up COVID-19 testing. Community Pharmacists can be mobilized to be part of meeting this goal, since they are the closest and most accessible healthcare practitioners in the communities. This study aimed at assessing the community pharmacist's knowledge, preparedness, and willingness to get involved in COVID-19 testing.
Methods: A cross-sectional self-administered structured questionnaire based survey of 449 consenting community pharmacists across Nigeria between April and May 2020 was used for this study. Descriptive and inferential statistics were done with the Statistical Package for Social Sciences, with the level of signifificance set at <0.05.
Results: Average knowledge of COVID-19 and its testing was displayed by 53.2% of the respondents, 336 (74.8%) stated that their pharmacies did not have a properly ventilated isolation room, and 401 (89.3%), were willing to be trained on how to use the test kits for COVID-19 testing. Community pharmacies that offffered comprehensive laboratory services were better prepared for COVID-19 testing (χ2 = 12.294, p = 0.000), and demographics of the respondents did not affffect their knowledge of COVID-19 and its testing (χ 2 = 10.469, p = 0.106).
Conclusion: Majority (53.2%) of the community pharmacists had average knowledge. Although, majority of the community pharmacies were not adequately prepared for COVID-19 testing, most of them were willing to be trained on how to use the test kits. The Government can explore this willingness by providing adequate training and equipment necessary for COVID-19 testing
References
World Health Organization. 2019. Coronavirus Disease. https://www.who.int/emergencies/diseases/novel.coronavirus. Accessed April 15, 2020.
WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020.
https://www.who.int/dg/speeches/detail/who- director-general-s-opening-remarks-at-the-media- briefing-on-covid-19---11-march-2020. Accessed April 15, 2020.
World Health Organization. Coronavirus disease 2019 (COVID-19) situation report 72. April 1, 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200401- sitrep-72-covid-19.pdf?sfvrsn=3dd8971b_2. Accessed April 15, 2020.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M and Wu J. (2020). SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected
Patients. The New England journal of medicine. 382(12):1177–1179.
https://doi.org/10.1056/NEJMc2001737
Yeo C, Kaushal S and Yeo D. (2020). Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? THE LANCET Gastroenterogy & Hepatology. 5(4): 335 – 337. https://doi.org/10.1016/S2468-1253(20)30048-0
Nigeria Centre for Disease Control. 2021. Guidance for the use of Approved COVID-19 Ag-RDTs in
Nigeria. https://covid19.ncdc.gov.ng/media/files/Guidance_for_the_use_of_approved_COVID-19_Ag_RDTs_in_Nigeria.pdf. Accessed January 20, 2021.
Nigeria Centre for Disease Control. 2020. National Strategy to Scale up Access to Coronavirus Disease Testing in Nigeria. https://covid19.ncdc.gov.ng/media/files/COVID19TestingStrategy_2ZWBQwh.pdf. Accessed June 3, 2020.
World Health Organization. Expanding COVID-19 tests in Africa's most populous nation. 2020.
https://www.afro.who.int/news/expanding-covid-19-tests-africas-most-populous-nation. Accessed: June 3, 2020.
Nigeria Centre for Disease Control. COVID-19 Situation Report 215. Wednesday, 30th September,
Nigeria Centre for Disease Control. COVID-19 Situation Report. Sunday, Wednesday, 20th January,
Todd A, Copeland A, Husband A, Kasim A and Bambra C. (2014). The positive pharmacy care law:
an area-level analysis of the relationship between community pharmacy distribution, urbanity and
social deprivation in England. BMJ Open. 4(8): e005764. http://dx.doi.org/10.1136/bmjopen-2014-
Giberson S, Yoder S and Lee MP. Improving Patient and Health System Outcomes Through Advanced Pharmacy Practice: A Report to the U.S. Surgeon General. Collingdale, PA: Diane Publishing
Company.2011.
Steltenpohl EA, Barry BK, Coley KC, McGivney MS, Olenak JL and Berenbrok LA. (2017). Point-of-Care Testing in Community Pharmacies: Keys to Success from Pennsylvania Pharmacists. Journal of
Pharmacy Practice. 1-7. https://doi.org/10.1177%2F0897190017735243
International Pharmaceutical Federation (FIP Health Advisory). Coronavirus 2019-nCoV Outbreak.
Information and interim guidelines for pharmacists and the pharmacy workforce (2020) The Netherlands. https://www.fip.org/fil e s/ cont ent/priority- areas/coronavirus/Coronavirus-guidance-update-ENGLISH.pdf, Accessed March 20, 2020.
Cadogan CA and Hughes CM. (2020). On the frontline against COVID-19: community pharmacists' contribution during a public health crisis. Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2020.03.015
U.S. Department of Health and Human Services. Guidance for Licensed Pharmacists, COVID-19
Testing and Immunity under the PREP Act. Wed, April 8, 2020. https://www.hhs.gov/sites/default/files/authorizing- licensed-pharmacists-to-order-and-administer-covid-19-tests.pdf. Accessed April 30, 2020.
World Health Organization. Commitment and call to action: Global collaboration to accelerate new
COVID-19 health technologies. 2020. https://www.who.int/news-room/detail/24-04-2020-commitment- and-call-to-action-global-collaboration-to-accelerate-new-covid-19-health-technologies. Accessed June 3, 2020.
Ungaro S, Wirth F, Azzopardi LM and Serracino-Inglott A. (2015). Point-of-Care testing for urine
analysis and microalbuminuria for diabetic patient management. Point Care. 14:71–72.
APhA. Annual Pharmacy-Based Influenza and Adult Immunization Survey 2013. Final Report.
Washington DC: APhA; 2013. https://www.pharmacist.com/sites/default/files/files/
Annual%20Immunization%20Survey%20Report.pdf. Accessed May 13, 2020.
World Health Organization. 2014. Antimicrobial Resistance Global Report on Surveillance, Geneva. https://www.who.int/antimicrobial-resistance/publications/surveillancereport/en/. Accessed June 15, 2019.
World Health Organization. Q&A: Hydroxychloroquine and COVID-19. 2020 https://www.who.int/news-room/q-a-detail/q-a-hydroxychloroquine-and-covid-19 Accessed June 3, 2020.
Huynh G, Nguyen TNH, Tran VK, Vo KN, Vo VT and Pham LA. (2020). Knowledge and attitude toward
COVID-19 among healthcare workers at District 2 Hospital, Ho Chi Minh City. Asian Pacific Journal of
Tropical Medicine . 13(6): 260–265. https://doi.org/10.4103/1995-7645.280396
Kamate SK, Sharma S, Thakar S, Srivastava D, Sengupta K, Hadi AJ, Chaudhary A, Joshi R and
Dhanker K. (2020). Assessing Knowledge, Attitudes and Practices of dental practitioners regarding the
COVID-19 pandemic: A multinational study. Dental and Medical Problems. 57(1): 11–17.
https://doi.org/10.17219/dmp/119743
Suleiman A, Bsisu I, Guzu H Santarisi A, Alsatari M, Abbad A, Jaber A, Harb T, Abuhejleh A, Nadi N,
Aloweidi A and Almustafa M. (2020). Preparedness of Frontline Doctors in Jordan Healthcare Facilities
to COVID-19 Outbreak. International Journal of Environmental Research and Public Health. 17(9): 3181-3192. https://doi.org/10.3390/ijerph17093181
Amadi CE, Lawal FO, Mbakwem AC, Ajuluchukwu JN and Oke DA. (2018). Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by
Community Pharmacists in Nigeria: a cross-sectional study. International Journal of Clinical Pharmacy. 40: 1587-1595. https://doi.org/10.1007/s11096-018-0744-3
Rodis JL and Thomas RA. (2006). Stepwise approach to developing point-of-care testing services
in the community/ambulatory pharmacy setting. Journal of the American Pharmacists Association.
(5):594-604. https://doi.org/10.1331/1544-3191.46.5.594.rodis
Saldarriaga EM, Vodicka E, La Rosa S and Valderrama M. (2017). Point-of-Care Testing for Anemia, Diabetes, and Hypertension: A Pharmacy-Based Model in Lima, Peru. Annals of Global Health. 83(2): 394–404. http://doi.org/10.1016/j.aogh.2017.03.514
Ogbonna BO, Ezenduka CC, Soni JS and Oparah AC. ( 2 0 1 5 ). Limitations to the dynamics of pharmaceutical care practice among community pharmacists in Enugu urban, southeast Nigeria.
Integrated Pharmacy Research and Practice. 4: 49–55. https://doi.org/10.2147/IPRP.S82911
McConnell DJ. (2020). Balancing the duty to treat with the duty to family in the context of the COVID-19 pandemic. Journal of Medical Ethics. 46(4): 360 – 363. https://doi.org/10.1136/medethics-2020-106250
Stevens W, Gous N, Ford N and Scott LE. (2014). Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions. BMC Medicine. 12 : 173 – 80. https://doi.org/10.1186/s12916-014-0173-7
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
